Novel Oral Anticoagulant versus Warfarin in Cancer Patients with Atrial Fibrillation: An 8-Year Population-Based Cohort Study

Background: Cancer patients with atrial fibrillation (AF) were excluded in the major clinical trials. We therefore investigated the efficacy and safety of novel oral anticoagulant (NOAC) versus warfarin in these patients. Methods: Data were retrieved from Taiwan National Health Insurance Research Da...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cancer
Hlavní autoři: Wu, Victor Chien-Chia, Wang, Chun-Li, Huang, Yu-Tung, Lan, Wen-Ching, Wu, Michael, Kuo, Chang-Fu, Chen, Shao-Wei, Chu, Pao-Hsien, Wen, Ming-Shien, Kuo, Chi-Ching, Chang, Shang-Hung
Médium: Artigo
Jazyk:Inglês
Vydáno: Ivyspring International Publisher 2020
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930400/
https://ncbi.nlm.nih.gov/pubmed/31892976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.36468
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky